Cinoxacin: Effectiveness Against Experimental Pyelonephritis in Rats

AUTOR(ES)

Holmes, D. H.

RESUMO

The antimicrobial activity of cinoxacin, 1-ethyl-4(1H)-oxo-[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid, previously reported as compound 64716, was determined and compared with other antimicrobial agents at a dosage of 12 mg/kg once daily in a descending pyelonephritis rat model with Escherichia coli and Proteus mirabilis as infecting organisms. Cinoxacin was considerably more effective than either nalidixic acid or oxolinic acid when all three were administered orally at 3 mg/kg four times daily. The presence of demonstrable serum activity with a high recovery in urine indicates cinoxacin possesses highly desirable properties of an effective oral chemotherapeutic agent for urinary tract infections.

Documentos Relacionados

• Cinoxacin: In Vitro Antibacterial Studies of a New Synthetic Organic Acid
• Cinoxacin: pharmacokinetics and tolerance in patients with normal and impaired renal function.
• Antipili antibody affords protection against experimental ascending pyelonephritis.
• SUSCEPTIBILITY OF RATS TO EXPERIMENTAL PYELONEPHRITIS DURING POTASSIUM DEPLETION*
• Experimental Candida albicans, Staphylococcus aureus, and Streptococcus faecalis pyelonephritis in diabetic rats.